Bibliography
1. Stein O, Sheinberg B, Schiff E, Mashiach S, Seidman DS. (1997) Prevalence of antibodies to cytomegalovirus in a parturient population in Israel. Isr J Med Sci. 1997 Jan;33(1):53-58
2. Feldman B, Yinon Y, Tepperberg Oikawa M, Yoeli R, Schiff E, Lipitz S (2011) Pregestational, periconceptional, and gestational primary maternal cytomegalovirus infection: prenatal diagnosis in 508 pregnancies. Am J Obstet Gynecol. 2011 Oct;205(4):342.e1-6. doi: 10.1016/j.ajog.2011.05.030
3. Bilavsky E, Pardo J, Attias J, Levy I, Magny JF, Ville Y, Leruez-Ville M, Amir J, (2016)
Clinical Implications for Children Born With Congenital Cytomegalovirus Infection Following a Negative Amniocentesis.
Clin Infect Dis. 2016 Jul 1;63(1):33-38
4. Bilavsky,E. Shahar-Nissan,K. Pardo,G. Attias,J Amir,J.(2016)
Hearing outcome of infants with congenital cytomegalovirus and hearing impairment
ADC Online First, published on January 29, 2016 as 10.1136/archdischild-2015-309154
5. Revello M.G, Tibaldi C, Masuelli G, and Others (2015)
Prevention of Primary Cytomegalovirus Infection in Pregnancy. EBioMedicine. 2015 Sep;2(9):1205–1210
6. Concetta Marsico and David W. Kimberlin (2017) Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment. Ital J Pediatr. 2017; 43: 38.
7. Jacob Amir, MD1,2, Joseph Attias, DSc1, and Joseph Pardo, MD2,3
Treatment of Late-Onset Hearing Loss in Infants With Congenital Cytomegalovirus Infection.
Clin Pediatr (Phila). 2014 May;53(5):444-8. doi: 10.1177/0009922813510204. Epub 2013 Nov 25
8. Bilavsky E, Pardo J, Attias J, Levy I, Magny JF, Ville Y, Leruez-Ville M, Amir J (2016)
Clinical Implications for Children Born With Congenital Cytomegalovirus Infection Following a Negative Amniocentesis.
Clin Infect Dis. 2016 Jul 1;63(1):33-38
9. Bilavsky E, Pardo J, Attias J, Levy I, Magny JF, Ville Y, Leruez-Ville M, Amir J, (2016)
Clinical Implications for Children Born With Congenital Cytomegalovirus Infection Following a Negative Amniocentesis.
Clin Infect Dis. 2016 Jul 1;63(1):33-38
The information on the site is updated as of its upload date. It only intends to provide information and is does not constitute and/or does not claim to a substitute for medical advice, medical opinion, exhaustive research on the subject or consultation with a healthcare specialist. Use of the website is the sole responsibility of its users and it does not replace the responsibility of the users to receive individual consultation by a qualified healthcare party, on a case by case basis. The website’s administration requests to stress that anyone searching for information on CMV must seek appropriate healthcare consultation.
Welcome to www.cmv.co.il – the website for the Israeli Association for CMV Pregnancy.
Users of the site must read these terms carefully before using the site, as using the site indicates the user’s consent to the terms.
The information on the site is updated as of its upload date. It only intends to provide information and is does not constitute and/or does not claim to a substitute for medical advice, medical opinion, exhaustive research on the subject or consultation with a healthcare specialist.
Use of the website is the sole responsibility of its users and it does not replace the responsibility of the users to receive individual consultation by a qualified healthcare party, on an individual case basis.
The website’s administration would like to stress that anyone seeking information on CMV must refer to appropriate healthcare consultation.
Users will have no claim, complaint or demand against the Association concerning the information presented on or through this site, its accuracy, reliability, completeness, relevancy, and the frequency of its publication.
Use of the information on the site and reliance on it will be the sole and complete responsibility of the users.
The Association reserves the right to update, modify, add or remove anything, without prior or late notice, at its sole discretion.
All copyright and intellectual property on the site belong to the Association, unless explicitly stated that the copyright of the protected information, or any part thereof, belongs to another party.
No part of the protected information may be copied, reproduced, distributed, marketed, publicly distributed, translated or disclosed to any third party without receiving the explicit written consent of the Association in advance.
I ratify my consent